It is a broadly described annual report of Beacon Pharmaceuticals Limited in the year of 2013. During the financial year, The Company’s Total Revenue BDT 1,226,906,195.00. Gross Profit BDT 616,918,200.00. Operating Profit BDT 207,391,975.00. Net Profit after tax for the year BDT 9,131,066.00. Sales Turnover has been increased by 25% over last year. Gross Profit has been increased by 17% over last year. Operating Profit has been reduced by 38.96% over last year. Net Profit after tax has been decreased by 87.86% over last year. Net Asset Value per share has been reduced by 87.87% over last year.
The Board of Directors of the Company has not recommended any dividend for the year ended 30th June 2013 since the Company does not make such profit to pay the dividend for the year. These financial statements are presented in Bangladesh Taka (Taka/Tk/BDT) which is the company’s functional currency. All financial information presented in Taka has been rounded off to the nearest Taka.
More Annual Report of Beacon Pharmaceuticals Limited:
- Annual Report 2010 of Beacon Pharmaceuticals Limited
- Annual Report 2012 of Beacon Pharmaceuticals Limited
- Annual Report 2013 of Beacon Pharmaceuticals Limited
- Annual Report 2014 of Beacon Pharmaceuticals Limited
- Annual Report 2015 of Beacon Pharmaceuticals Limited
- Annual Report 2016 of Beacon Pharmaceuticals Limited
